Hi FFS,366 enrollees in P2b./, 122 in the 0.5 mg...

Hi FFS,

366 enrollees in P2b
./, 122 in the 0.5 mg group
————————————
= 244 patients
./. 4 drop-outs (2 died of age, 1 diagnosed with squamous lung cell carcinoma shortly after baseline exam, 1 for unknown reasons)
————————————-
= 240 patients
./. 29 RAP patients (as excluded in P3 anyway)
————————————-
= 211 patients
./. 31 predominantly classic lesion patients (while enrolled in P3, they will not be part of topline readout, but at a later point of time)
————————————-
= 180 patients

Unfortunately I cannot bridge the 180 patients left to the 87 + 85 = 172 patients in the slide. But I guess it does not really matter.

Hope this helps at least a little bit.